DRAVPa2181 |
Sequence 12 from Patent US20230256049A1 |
Synthetic peptide |
SARS-CoV-2 |
US20230256049A1 |
DRAVPa2182 |
Sequence 13 from Patent US20230256049A1 |
Synthetic peptide |
SARS-CoV-2 |
US20230256049A1 |
DRAVPa2183 |
Sequence 14 from Patent US20230256049A1 |
Synthetic peptide |
SARS-CoV-2 |
US20230256049A1 |
DRAVPa2184 |
Sequence 15 from Patent US20230256049A1 |
Synthetic peptide |
SARS-CoV-2 |
US20230256049A1 |
DRAVPa2185 |
Sequence 16 from Patent US20230256049A1 |
Synthetic peptide |
SARS-CoV-2 |
US20230256049A1 |
DRAVPa2186 |
Sequence 32 from Patent US20230256049A1 |
Synthetic peptide |
SARS-CoV-2 |
US20230256049A1 |
DRAVPa2187 |
Sequence 33 from Patent US20230256049A1 |
Synthetic peptide |
SARS-CoV-2 |
US20230256049A1 |
DRAVPa2188 |
Sequence 34 from Patent US20230256049A1 |
Synthetic peptide |
SARS-CoV-2 |
US20230256049A1 |
DRAVPa2189 |
Sequence 35 from Patent US20230256049A1 |
Synthetic peptide |
SARS-CoV-2 |
US20230256049A1 |
DRAVPa2190 |
Sequence 40 from Patent US20230256049A1 |
Synthetic peptide |
SARS-CoV-2 |
US20230256049A1 |
DRAVPa2191 |
Sequence 41 from Patent US20230256049A1 |
Synthetic peptide |
SARS-CoV-2 |
US20230256049A1 |
DRAVPa2192 |
Sequence 42 from Patent US20230256049A1 |
Synthetic peptide |
SARS-CoV-2 |
US20230256049A1 |
DRAVPa2193 |
Sequence 43 from Patent US20230256049A1 |
Synthetic peptide |
SARS-CoV-2 |
US20230256049A1 |
DRAVPa2194 |
Sequence 44 from Patent US20230256049A1 |
Synthetic peptide |
SARS-CoV-2 |
US20230256049A1 |
DRAVPa2195 |
Sequence 45 from Patent US20230256049A1 |
Synthetic peptide |
SARS-CoV-2 |
US20230256049A1 |
DRAVPa2196 |
Sequence 46 from Patent US20230256049A1 |
Synthetic peptide |
SARS-CoV-2 |
US20230256049A1 |
DRAVPa2197 |
Sequence 47 from Patent US20230256049A1 |
Synthetic peptide |
SARS-CoV-2 |
US20230256049A1 |
DRAVPa2198 |
Sequence 48 from Patent US20230256049A1 |
Synthetic peptide |
SARS-CoV-2 |
US20230256049A1 |
DRAVPa2199 |
Sequence 49 from Patent US20230256049A1 |
Synthetic peptide |
SARS-CoV-2 |
US20230256049A1 |
DRAVPa2200 |
Sequence 50 from Patent US20230256049A1 |
Synthetic peptide |
SARS-CoV-2 |
US20230256049A1 |